Himadri Speciality Chemical
- P/E
- 33.18
Key Fundamentals
SmallcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 22.10%
- Debt to Equity
- 0.23
- EPS (TTM)
- ₹16.94
- Book Value
- ₹101.77
- Market Cap
- —
- P/E (TTM)
- 33.18
- P/B
- 5.52
- ROE
- 17.80%
- Dividend Yield
- 0.15%
- EBITDA
- ₹1,133 Cr
- 52W High
- ₹819.50
- 52W Low
- ₹418.50
- Day Range
- ₹523.75 – ₹564.95
- Volume
- 35,36,122
Peer Comparison
Commodities › Chemicals › Specialty Chemicals › Carbon Black
| ₹562.05 | 33.18 | ₹26,869 Cr | 5.52 | 0.15% | 17.80% | 22.10% | ₹5,595 Cr | ₹859 Cr | |
| ₹278.45 | 41.94 | ₹10,993 Cr | 2.70 | 1.63% | 5.56% | 7.75% | ₹8,549 Cr | ₹259 Cr | |
| Median 2 companies | ₹420.25 | 37.56 | ₹18,931 Cr | 4.11 | 0.89% | 11.68% | 14.93% | ₹7,072 Cr | ₹559 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 98/100
Category scores
- Quality
- 40
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 42
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 90
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 73
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 27
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is expected to give good quarter
- Company has delivered good profit growth of 73.7% CAGR over last 5 years
No weaknesses listed
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 5 | 3 |
| Oscillators | Bearish | 3 | 5 | 1 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 43.69
- Neutral
- MACD (12,26,9)
- −36.21
- Bearish
- SMA (50)
- 634.26
- Bearish
- SMA (200)
- 594.20
- Bearish
As of
Analyst Rating
0 of 1 analyst rates Buy, 1 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +14.71% |
|---|---|
| 5Y | +22.66% |
| 3Y | +3.76% |
| 1Y | +1.04% |
| TTM | +25.31% |
Net profit
| 10Y | Turned to profit |
|---|---|
| 5Y | +74.25% |
| 3Y | +51.76% |
| 1Y | +36.04% |
| TTM | +31.95% |
Operating cash flow
| 10Y | +2.58% |
|---|---|
| 5Y | Turned positive |
| 3Y | +91.97% |
| 1Y | −14.54% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +8.29 pp |
|---|---|
| 5Y | +12.84 pp |
| 3Y | +11.08 pp |
| 1Y | +2.13 pp |
| TTM | −1.42 pp |
Revenue by year
| Mar 2017 | ₹1,341 Cr |
|---|---|
| Mar 2018 | ₹2,022 Cr |
| Mar 2019 | ₹2,422 Cr |
| Mar 2020 | ₹1,806 Cr |
| Mar 2021 | ₹1,679 Cr |
| Mar 2022 | ₹2,791 Cr |
| Mar 2023 | ₹4,172 Cr |
| Mar 2024 | ₹4,185 Cr |
| Mar 2025 | ₹4,613 Cr |
| Mar 2026 | ₹4,661 Cr |
Net profit by year
| Mar 2017 | ₹82.00 Cr |
|---|---|
| Mar 2018 | ₹248 Cr |
| Mar 2019 | ₹324 Cr |
| Mar 2020 | ₹205 Cr |
| Mar 2021 | ₹47.00 Cr |
| Mar 2022 | ₹39.00 Cr |
| Mar 2023 | ₹216 Cr |
| Mar 2024 | ₹411 Cr |
| Mar 2025 | ₹555 Cr |
| Mar 2026 | ₹755 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Himadri Speciality Chemical Ltd trades at ₹562.05 as of 2026-11-04 with a market cap of ₹26,869 Cr. The company has delivered strong compounded profit growth of 74% CAGR over 5 years and maintains a low debt-to-equity ratio of 0.16, though the stock trades at a PE of 33.18x and has corrected roughly 31% from its 52-week high of ₹819.50.
- Exceptional 5-year compounded profit growth of 74% CAGR demonstrates sustained earnings expansion well above the broader chemicals sector average
- Very low debt-to-equity ratio of 0.16 indicates a conservatively funded balance sheet, providing financial flexibility for future capacity expansion or acquisitions
- ROCE of 21.01% reflects efficient capital deployment and strong underlying business economics
- TTM sales growth of 25% signals healthy revenue momentum, a sharp acceleration from the 3-year compounded sales growth of just 4%
- ROE of 15.86% (with a 3-year average of 17% and last year at 18%) shows a consistent ability to generate returns on shareholder equity
- Stock has delivered a 5-year CAGR of 62%, significantly outperforming broader market indices over the same period
- TTM profit growth of 30% on top of an already high base indicates that earnings momentum has not yet plateaued
- 10-year compounded profit growth of 44% demonstrates the company's long-track-record of scaling earnings through multiple business cycles
- The stock has fallen approximately 31% from its 52-week high of ₹819.50, suggesting possible deterioration in market sentiment or stretched prior valuations
- Price-to-book ratio of 5.52x is high, implying the market is pricing in significant future growth that may or may not materialise
- Dividend yield of just 0.15% offers negligible income to shareholders, meaning returns depend almost entirely on capital appreciation
- 3-year compounded sales growth of only 4% contrasts sharply with the TTM figure of 25%, raising questions about whether the recent revenue acceleration is sustainable or one-off in nature
- Specialty chemicals businesses are inherently cyclical and tied to raw material price swings; a downturn in end-market demand could compress margins despite the recent profit trajectory
- The gap between 5-year ROE of 14% and the last year's 18% suggests recent returns may be benefiting from a cyclical peak rather than a structural shift
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Himadri Speciality Chemical shows disciplined short-term debt management, rolling over ₹150 crore in commercial paper at a competitive 6.60% rate while redeeming the prior tranche on schedule. The Golden Peacock Sustainability Award adds to the company's ESG credentials in the chemicals space. No material headwinds surfaced this week. Near-term focus remains on whether the company can leverage its sustainability positioning into stronger institutional interest and order flow.
- Golden Peacock Sustainability Award Oct 8
Himadri Speciality Chemical won the Golden Peacock Award for Sustainability 2026 in the chemical sector, recognizing its commitment to green operations and responsible innovation.
- ₹150Cr CP allotted to Kotak Oct 9
Himadri allotted ₹150 crore in commercial paper to Kotak Mahindra Bank, an 80-day instrument at a 6.60% annual discount rate.
- ₹150Cr CP redeemed on time Oct 7
Himadri fully redeemed ₹150 crore in commercial papers on October 7, 2026, confirming timely repayment as per issuance terms.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,005 | 1,053 | 1,177 | 1,200 | 1,137 | 1,141 | 1,135 | 1,118 | 1,071 | 1,184 | 1,288 | 1,432 | 1,691 |
| Expenses | 847 | 879 | 997 | 1,008 | 929 | 920 | 901 | 873 | 838 | 941 | 1,046 | 1,144 | 1,376 |
| Operating Profit | 158 | 174 | 180 | 192 | 208 | 221 | 233 | 245 | 233 | 243 | 242 | 288 | 315 |
| OPM % | 16% | 17% | 15% | 16% | 18% | 19% | 21% | 22% | 22% | 20% | 19% | 20% | 19% |
| Other Income | 10 | 10 | 12 | 13 | 14 | 12 | 14 | 27 | 36 | 47 | 62 | 56 | 42 |
| Interest | 16 | 21 | 14 | 13 | 11 | 12 | 9 | 16 | 15 | 16 | 17 | 22 | 28 |
| Depreciation | 12 | 13 | 13 | 13 | 13 | 15 | 14 | 15 | 17 | 18 | 19 | 21 | 22 |
| PBT | 139 | 150 | 166 | 179 | 197 | 206 | 224 | 241 | 237 | 255 | 268 | 301 | 307 |
| Tax % | 28% | 28% | 30% | 31% | 31% | 31% | 31% | 26% | 26% | 25% | 23% | 24% | 25% |
| Net Profit | 101 | 109 | 115 | 123 | 136 | 141 | 155 | 179 | 176 | 192 | 208 | 228 | 231 |
| EPS (₹) | 2.29 | 2.47 | 2.34 | 2.48 | 2.74 | 2.88 | 3.15 | 3.68 | 3.57 | 3.81 | 3.98 | 4.55 | 4.6 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,437 | 1,182 | 1,341 | 2,022 | 2,422 | 1,806 | 1,679 | 2,791 | 4,172 | 4,185 | 4,613 | 4,661 | 5,595 |
| Expenses | 1,313 | 1,036 | 1,107 | 1,569 | 1,863 | 1,525 | 1,549 | 2,635 | 3,773 | 3,540 | 3,758 | 3,699 | 4,507 |
| Operating Profit | 124 | 146 | 233 | 452 | 560 | 280 | 131 | 156 | 399 | 645 | 854 | 962 | 1,087 |
| OPM % | 9% | 12% | 17% | 22% | 23% | 16% | 8% | 6% | 10% | 15% | 19% | 21% | 19% |
| Other Income | 13 | 9 | 6 | 12 | 8 | 8 | 14 | −17 | −2 | 43 | 52 | 171 | 207 |
| Interest | 103 | 111 | 82 | 70 | 71 | 55 | 33 | 36 | 66 | 64 | 45 | 64 | 84 |
| Depreciation | 59 | 67 | 33 | 33 | 34 | 39 | 47 | 50 | 51 | 50 | 55 | 68 | 79 |
| PBT | −24 | −23 | 125 | 361 | 462 | 194 | 65 | 53 | 280 | 574 | 806 | 1,001 | 1,131 |
| Tax % | −49% | −19% | 34% | 31% | 30% | −6% | 27% | 27% | 23% | 28% | 31% | 25% | — |
| Net Profit | −13 | −19 | 82 | 248 | 324 | 205 | 47 | 39 | 216 | 411 | 555 | 755 | 859 |
| EPS (₹) | −0.32 | −0.44 | 1.98 | 5.91 | 7.75 | 4.91 | 1.13 | 0.98 | 4.99 | 8.34 | 11.25 | 14.89 | 16.94 |
| Div. Payout % | 0% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 5% | 2% | 2% | 3% | 13% | 20% | 5% | 6% | 5% | 5% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 43 | 49 | 49 | 50 | 50 |
| Reserves | 750 | 837 | 988 | 1,373 | 1,590 | 1,692 | 1,751 | 1,826 | 2,237 | 2,996 | 3,672 | 4,656 | 5,085 |
| Borrowings | 1,124 | 887 | 774 | 660 | 476 | 505 | 729 | 587 | 842 | 605 | 313 | 770 | 1,160 |
| Other Liabilities | 329 | 296 | 308 | 341 | 680 | 323 | 269 | 999 | 555 | 798 | 621 | 830 | 682 |
| Total Liabilities | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 6,306 | 6,977 |
| Fixed Assets | 1,228 | 1,180 | 1,174 | 1,178 | 1,170 | 1,475 | 1,468 | 1,546 | 1,515 | 1,534 | 1,605 | 1,942 | 2,016 |
| CWIP | 14 | 31 | 13 | 22 | 133 | 158 | 160 | 77 | 94 | 67 | 185 | 372 | 370 |
| Investments | 23 | 53 | 87 | 273 | 179 | 47 | 66 | 113 | 132 | 478 | 582 | 1,060 | 1,250 |
| Other Assets | 977 | 798 | 838 | 943 | 1,305 | 882 | 1,098 | 1,718 | 1,938 | 2,371 | 2,283 | 2,933 | 3,341 |
| Total Assets | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 6,306 | 6,977 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 212 | 296 | 205 | 258 | 476 | 283 | −40 | 331 | 54 | 405 | 447 | 382 |
| Investing | 128 | −6 | 10 | −50 | −224 | −214 | −114 | −28 | −397 | −405 | −235 | −963 |
| Financing | −348 | −278 | −233 | −200 | −257 | −41 | 165 | −182 | 377 | 7 | −271 | 590 |
| Net Cash Flow | −7 | 12 | −18 | 8 | −6 | 28 | 11 | 121 | 34 | 7 | −60 | 10 |
| Free Cash Flow | 184 | 281 | 201 | 195 | 272 | 36 | −76 | 308 | −22 | 352 | 276 | −63 |
| CFO/EBITDA | 169 | 203 | 98 | 75 | 102 | 113 | −20 | 223 | 25 | 77 | 69 | 64 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82 | 63 | 60 | 49 | 55 | 61 | 100 | 66 | 44 | 57 | 50 | 55 |
| Inventory Days | 122 | 138 | 164 | 112 | 124 | 121 | 100 | 125 | 61 | 85 | 68 | 96 |
| Days Payable | 36 | 50 | 74 | 39 | 100 | 68 | 45 | 127 | 39 | 69 | 28 | 47 |
| Cash Conversion Cycle | 168 | 151 | 150 | 122 | 79 | 113 | 155 | 65 | 66 | 73 | 90 | 103 |
| Working Capital Days | 4 | −22 | 19 | 29 | 40 | 10 | 15 | −1 | 1 | 32 | 69 | 57 |
| ROCE % | 3% | 5% | 11% | 22% | 25% | 11% | 4% | 5% | 13% | 19% | 22% | 22% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Himadri Speciality Chemical insights
64 extracted metrics across FY01–FY27.
Documents
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Jan 2026Transcript PPT Recording
- Q2 FY26 concall · Oct 2025Transcript PPT Recording
- 10 Jul 2026
- 19 Mar 2026
- 10 Sep 2025
- 31 Jul 2025
- 21 Mar 2025
- General announcements 28 Oct 2026
Frequently Asked Questions about Himadri Speciality Chemical
What does Himadri Speciality Chemical Ltd do?
Where is Himadri Speciality Chemical Ltd (HSCL) listed?
Which sector does Himadri Speciality Chemical Ltd belong to?
What is the PE ratio of Himadri Speciality Chemical Ltd?
What is the 52-week high and low of Himadri Speciality Chemical Ltd?
Does Himadri Speciality Chemical Ltd pay dividends?
What is the Return on Equity (ROE) of Himadri Speciality Chemical Ltd?
Company Information
Himadri Speciality Chemical is primarily engaged in the manufacturing of carbon materials and chemicals. It is the No.1 coal pitch manufacturer in India and is the only company to manufacture advanced carbon material in India. It is also the largest player of Naphthalene and SNF in India.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/HSCL.md for Himadri Speciality Chemical Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.